Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Oct;70(4):762–768. doi: 10.1172/JCI110672

Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.

M C Jordan, V L Mar
PMCID: PMC370284  PMID: 6288769

Abstract

Cytomegalovirus (CMV) is a major pathogen in the compromised host where many infections result from activation of latent virus. Because latent CMV infection has been difficult to study in humans, murine models have been developed and investigated. Here, we describe the events involved in activation of latent murine CMV (MCMV) from spleen explants in vitro. Infectious virus was no longer detectable in murine organs 4 mo after inoculatioN of 10(5) plaque-forming units of MCMV. 8-10 d after establishment of spleen explants, phagocytic macrophages covered 70-80% of the surface of tissue culture dishes, and lymphocytes were continuously released, reaching titers of 10(6) cells/ml. MCMV was produced spontaneously after 12-18 d from spleen explant cultures of 33 of 34 mice. Virus replicated to titers above 10(4) plaque-forming units/ml, remained at that level for 4-5 wk, and gradually disappeared as macrophages were lysed. Although MCMV was shown to be replicating in macrophages, these cells were never found to be the source of latent virus. Cell separation studies indicated that latent virus was initially released from 70% of lymphocyte cultures and was associated with the B cell enriched fraction. We conclude that MCMV establishes nonreplicating dormant infection in B lymphocytes, activates from these cells in spleen explant cultures, and is augmented in titer by replication in permissive macrophages.

Full text

PDF
762

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams A., Lindahl T. Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1477–1481. doi: 10.1073/pnas.72.4.1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baringer J. R. Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med. 1974 Oct 17;291(16):828–830. doi: 10.1056/NEJM197410172911606. [DOI] [PubMed] [Google Scholar]
  3. Baringer J. R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. doi: 10.1056/NEJM197303292881303. [DOI] [PubMed] [Google Scholar]
  4. Bastian F. O., Rabson A. S., Yee C. L., Tralka T. S. Herpesvirus hominis: isolation from human trigeminal ganglion. Science. 1972 Oct 20;178(4058):306–307. doi: 10.1126/science.178.4058.306. [DOI] [PubMed] [Google Scholar]
  5. Bayer W. L., Tegtmeier G. E. The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody. Yale J Biol Med. 1976 Mar;49(1):5–12. [PMC free article] [PubMed] [Google Scholar]
  6. Bennett B. Isolation and cultivation in vitro of macrophages from various sources in the mouse. Am J Pathol. 1966 Jan;48(1):165–181. [PMC free article] [PubMed] [Google Scholar]
  7. Brautigam A. R., Dutko F. J., Olding L. B., Oldstone M. B. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol. 1979 Aug;44(2):349–359. doi: 10.1099/0022-1317-44-2-349. [DOI] [PubMed] [Google Scholar]
  8. Cheung K. S., Huang E. S., Lang D. J. Murine cytomegalovirus: detection of latent infection by nucleic acid hybridization technique. Infect Immun. 1980 Mar;27(3):851–854. doi: 10.1128/iai.27.3.851-854.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheung K. S., Lang D. J. Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells. Infect Immun. 1977 Feb;15(2):568–575. doi: 10.1128/iai.15.2.568-574.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cheung K. S., Lang D. J. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J Infect Dis. 1977 May;135(5):841–845. doi: 10.1093/infdis/135.5.841. [DOI] [PubMed] [Google Scholar]
  11. Cook M. L., Bastone V. B., Stevens J. G. Evidence that neurons harbor latent herpes simplex virus. Infect Immun. 1974 May;9(5):946–951. doi: 10.1128/iai.9.5.946-951.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dutko F. J., Oldstone M. B. Murine cytomegalovirus infects spermatogenic cells. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2988–2991. doi: 10.1073/pnas.76.6.2988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Glazer J. P., Friedman H. M., Grossman R. A., Starr S. E., Barker C. F., Perloff L. J., Huang E. S., Plotkin S. A. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med. 1979 Nov;91(5):676–683. doi: 10.7326/0003-4819-91-5-676. [DOI] [PubMed] [Google Scholar]
  14. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ho M., Suwansirikul S., Dowling J. N., Youngblood L. A., Armstrong J. A. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med. 1975 Nov 27;293(22):1109–1112. doi: 10.1056/NEJM197511272932201. [DOI] [PubMed] [Google Scholar]
  16. Ho M. The lymphocyte in infections with Epstein-Barr virus and cytomegalovirus. J Infect Dis. 1981 Jun;143(6):857–862. doi: 10.1093/infdis/143.6.857. [DOI] [PubMed] [Google Scholar]
  17. Hudson J. B., Loh L., Misra V., Judd B., Suzuki J. Multiple interactions between murine cytomegalovirus and lymphoid cells in vitro. J Gen Virol. 1978 Jan;38(1):149–159. doi: 10.1099/0022-1317-38-1-149. [DOI] [PubMed] [Google Scholar]
  18. Jordan M. C. Adverse effects of cytomegalovirus vaccination in mice. J Clin Invest. 1980 Apr;65(4):798–803. doi: 10.1172/JCI109730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jordan M. C. Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect Immun. 1978 Jul;21(1):275–280. doi: 10.1128/iai.21.1.275-280.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jordan M. C., Shanley J. D., Stevens J. G. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol. 1977 Nov;37(2):419–423. doi: 10.1099/0022-1317-37-2-419. [DOI] [PubMed] [Google Scholar]
  21. Jordan M. C., Takagi J. L., Stevens J. G. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection. J Infect Dis. 1982 May;145(5):699–705. doi: 10.1093/infdis/145.2.699. [DOI] [PubMed] [Google Scholar]
  22. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  23. Kane R. C., Rousseau W. E., Noble G. R., Tegtmeier G. E., Wulff H., Herndon H. B., Chin T. D., Bayer W. L. Cytomegalovirus infection in a volunteer blood donor population. Infect Immun. 1975 Apr;11(4):719–723. doi: 10.1128/iai.11.4.719-723.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lang D. J. Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis. Arch Gesamte Virusforsch. 1972;37(4):365–377. doi: 10.1007/BF01241460. [DOI] [PubMed] [Google Scholar]
  25. Mage M. G., McHugh L. L., Rothstein T. L. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods. 1977;15(1):47–56. doi: 10.1016/0022-1759(77)90016-3. [DOI] [PubMed] [Google Scholar]
  26. Mayo D. R., Armstrong J. A., Ho M. Reactivation of murine cytomegalovirus by cyclophosphamide. Nature. 1977 Jun 23;267(5613):721–723. doi: 10.1038/267721a0. [DOI] [PubMed] [Google Scholar]
  27. Mayo D., Armstrong J. A., Ho M. Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression. J Infect Dis. 1978 Dec;138(6):890–896. doi: 10.1093/infdis/138.6.890. [DOI] [PubMed] [Google Scholar]
  28. Mims C. A., Gould J. The role of macrophages in mice infected with murine cytomegalovirus. J Gen Virol. 1978 Oct;41(1):143–153. doi: 10.1099/0022-1317-41-1-143. [DOI] [PubMed] [Google Scholar]
  29. Morgan C., Rose H. M., Mednis B. Electron microscopy of herpes simplex virus. I. Entry. J Virol. 1968 May;2(5):507–516. doi: 10.1128/jvi.2.5.507-516.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Naraqi S., Jackson G. G., Jonasson O., Rubenis M. Search for latent cytomegalovirus in renal allografts. Infect Immun. 1978 Feb;19(2):699–703. doi: 10.1128/iai.19.2.699-703.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Neff B. J., Weibel R. E., Buynak E. B., McLean A. A., Hilleman M. R. Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169. Proc Soc Exp Biol Med. 1979 Jan;160(1):32–37. doi: 10.3181/00379727-160-40382. [DOI] [PubMed] [Google Scholar]
  32. Numazaki Y., Yano N., Morizuka T., Takai S., Ishida N. Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women. Am J Epidemiol. 1970 Apr;91(4):410–417. doi: 10.1093/oxfordjournals.aje.a121151. [DOI] [PubMed] [Google Scholar]
  33. Olding L. B., Jensen F. C., Oldstone M. B. Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med. 1975 Mar 1;141(3):561–572. doi: 10.1084/jem.141.3.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Plotkin S. A., Farquhar J., Horberger E. Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J Infect Dis. 1976 Nov;134(5):470–475. doi: 10.1093/infdis/134.5.470. [DOI] [PubMed] [Google Scholar]
  35. Roche J. K., Cheung K. S., Boldogh I., Huang E. S., Lang D. J. Cytomegalovirus: detection in human colonic and circulating mononuclear cells in association with gastrointestinal disease. Int J Cancer. 1981 May 15;27(5):659–667. doi: 10.1002/ijc.2910270513. [DOI] [PubMed] [Google Scholar]
  36. Selgrade M. K., Osborn J. E. Role of macrophages in resistance to murine cytomegalovirus. Infect Immun. 1974 Dec;10(6):1383–1390. doi: 10.1128/iai.10.6.1383-1390.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shanley J. D., Jordan M. C., Cook M. L., Stevens J. G. Pathogenesis of reactivated latent murine cytomegalovirus infection. Am J Pathol. 1979 Apr;95(1):67–80. [PMC free article] [PubMed] [Google Scholar]
  38. Shanley J. D., Pesanti E. L. Replication of murine cytomegalovirus in lung macrophages: effect of phagocytosis of bacteria. Infect Immun. 1980 Sep;29(3):1152–1159. doi: 10.1128/iai.29.3.1152-1159.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Starr S. E., Allison A. C. Role of T lymphocytes in recovery from murine cytomegalovirus infection. Infect Immun. 1977 Aug;17(2):458–462. doi: 10.1128/iai.17.2.458-462.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Stevens J. G., Cook M. L. Latent herpes simplex virus in spinal ganglia of mice. Science. 1971 Aug 27;173(3999):843–845. doi: 10.1126/science.173.3999.843. [DOI] [PubMed] [Google Scholar]
  41. Stevens J. G. Latent characteristics of selected herpesviruses. Adv Cancer Res. 1978;26:227–256. doi: 10.1016/s0065-230x(08)60089-5. [DOI] [PubMed] [Google Scholar]
  42. Tegtmeyer P. J., Craighead J. E. Infection of adult mouse macrophages in vitro with cytomegalovirus. Proc Soc Exp Biol Med. 1968 Dec;129(3):690–694. doi: 10.3181/00379727-129-33399. [DOI] [PubMed] [Google Scholar]
  43. Weller T. H. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II. N Engl J Med. 1971 Jul 29;285(5):267–274. doi: 10.1056/NEJM197107292850507. [DOI] [PubMed] [Google Scholar]
  44. Wise T. G., Manischewitz J. E., Quinnan G. V., Aulakh G. S., Ennis F. A. Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique. J Gen Virol. 1979 Aug;44(2):551–556. doi: 10.1099/0022-1317-44-2-551. [DOI] [PubMed] [Google Scholar]
  45. Wu B. C., Ho M. Characteristics of infection of B and T lymphocytes from mice after inoculation with cytomegalovirus. Infect Immun. 1979 Jun;24(3):856–864. doi: 10.1128/iai.24.3.856-864.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yeager A. S., Grumet F. C., Hafleigh E. B., Arvin A. M., Bradley J. S., Prober C. G. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr. 1981 Feb;98(2):281–287. doi: 10.1016/s0022-3476(81)80662-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES